HeartBeam wins new U.S. patent expanding cable-free ECG device sensing capabilities
BEAT•Patent portfolio
The company said it now holds 26 issued patents worldwide across ECG signal acquisition, synthesis algorithms, diagnostic applications, device hardware, and an on-demand 12-lead patch.
New patent expands sensing capabilities
HeartBeam received allowance of a new U.S. patent covering acoustic sensing and thoracic-impedance measurement integrated into its credit card-sized, cable-free ECG device.
The company said the patent expands the platform into heart-sound monitoring and chest-fluid tracking, targeting structural heart disease screening and earlier heart-failure intervention.
Claims cover digital stethoscope and chest-fluid measurement
Claims cover acoustic sensors built into the device’s foldable arms, positioning it for use as a digital stethoscope without changing the form factor.
Claims also cover thoracic-impedance measurement using finger electrodes to inject current, measuring voltage across chest electrodes to estimate fluid in the chest.
